StockWatch
·

IPCA LABORATORIES LTD.

BSE: 524494

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-413.15592.471.6K2.6KQ3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27

Margin Trend

percentage
OPM %NPM %
-8.604.9118.4331.94Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
PeriodQ2 FY27Q1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25
INCOME
Revenue2.3K+6.4%2.1K+16.8%1.8K-1.7%1.8K-4.4%1.9K+10.5%1.7K+6.6%1.6K-1.5%1.7K
Other Income18.92+8.6%17.42-41.7%29.88+67.7%17.82-18.7%21.92-12.4%25.02+16.4%21.49+23.4%17.41
Total Income2.3K+6.5%2.1K+15.9%1.8K-1.0%1.9K-4.6%2.0K+10.2%1.8K+6.7%1.7K-1.2%1.7K
EXPENSES
Expenditure1.7K+7.4%1.6K+10.7%1.5K+1.3%1.4K-6.4%1.5K+9.1%1.4K+4.0%1.4K+2.8%1.3K
Tax146.42+3.0%142.12+62.3%87.56-23.0%113.77+9.8%103.57+9.4%94.71+15.2%82.20-6.5%87.96
PROFIT
PBT533.71+3.6%515.41+47.3%349.85-16.1%417.22+2.2%408.31+14.5%356.75+1980.2%17.15-95.2%355.52
Net Profit387.29+3.8%373.29+42.3%262.29-13.6%303.45-0.4%304.74+16.3%262.04+502.8%-65.05-124.3%267.56
KEY METRICS
OPM %26.47%-0.79pp27.26%+5.17pp22.09%-3.79pp25.88%+1.81pp24.07%+0.78pp23.29%+18.59pp4.70%-11.25pp15.95%
NPM %17.03%-0.44pp17.47%+3.25pp14.22%-2.07pp16.29%+0.68pp15.61%+0.82pp14.79%+18.71pp-3.92%-19.85pp15.93%
EPS15.27+3.8%14.71+42.3%10.34-13.5%11.96-0.4%12.01+16.3%10.33+303.5%2.56-75.7%10.55

Corporate Events

Board MeetingIPCALAB
2026
5Nov

Board Meeting

The meeting of the Board of Directors will be held to consid…

BSE Filing ↗
Board MeetingIPCALAB
2026
30Sep

Board Meeting

The Board of Directors met to take on record the Standalone …

BSE Filing ↗
Board MeetingIPCALAB
2026
13Aug

Board Meeting

The 76th Annual General Meeting (AGM) of the Company will be…

BSE Filing ↗
DividendIPCALAB
2026
7Aug

₹6 / share

BSE Filing ↗
DividendIPCALAB
2025
5Aug

₹2 / share

BSE Filing ↗
DividendIPCALAB
2024
27Nov

₹2 / share

BSE Filing ↗
Board MeetingIPCALAB
2024
14Nov

Board Meeting

consider and approve Standalone and Consolidated Financial R…

BSE Filing ↗
Board MeetingIPCALAB
2024
30Sep

Board Meeting

Integration and consolidation of the generics formulations b…

BSE Filing ↗
Board MeetingIPCALAB
2024
29May

Board Meeting

Consideration and approval of Standalone and Consolidated Au…

BSE Filing ↗
Board MeetingIPCALAB
2024
14Feb

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing ↗
DividendIPCALAB
2023
22Nov

₹2 / share

BSE Filing ↗
Board MeetingIPCALAB
2023
10Nov

Board Meeting

Consideration and approval of Standalone and Consolidated Un…

BSE Filing ↗